Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HZ/su vaccine in adults with solid tumors receiving chemotherapy
2012-002966-11Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2012
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in herpes zoster (HZ) comparing GSK 1437173A vaccine with Placebo (2 arms). Primary endpoint: Anti-gE humoral immunogenicity. Started Dec 2012; status: completed.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on 2012-002966-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002966-11.